WHO Expert Committee on Biological Standardization : fifty-second report.

Annotation

Saved in:
Bibliographic Details
Corporate Authors: WHO Expert Committee on Biological Standardization. Meeting, World Health Organization
Format: eBook
Language:English
Published: Geneva : World Health Organization, 2004.
Series:Technical report series (World Health Organization) ; 924.
Subjects:
Online Access:Click for online access

MARC

LEADER 00000cam a2200000 a 4500
001 ocn317384275
003 OCoLC
005 20240623213015.0
006 m o d
007 cr |||||||||||
008 060311s2004 sz a ob 100 0 eng d
040 |a UK-RwCLS  |b eng  |e pn  |c DLC  |d OCLCQ  |d INU  |d NTE  |d YDXCP  |d OCLCQ  |d IDEBK  |d EBLCP  |d OCLCO  |d OCLCQ  |d OCLCF  |d OCLCQ  |d DEBSZ  |d HS0  |d DKDLA  |d DEBBG  |d AU@  |d OCL  |d OCLCQ  |d OCLCA  |d ZCU  |d OCLCQ  |d MERUC  |d OCLCQ  |d STF  |d ICG  |d OCLCQ  |d XFH  |d WT2  |d REB  |d CCO  |d E7B  |d COCUF  |d U3W  |d FVL  |d AZK  |d MOR  |d PIFBR  |d WRM  |d NRAMU  |d VT2  |d OCLCQ  |d OCLCO  |d DKC  |d OCLCQ  |d UEJ  |d UKCRE  |d OCLCQ  |d VLB  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 70773992  |a 191039473  |a 496991904  |a 559332398  |a 646729274  |a 722341000  |a 728025062  |a 738625467  |a 827830783  |a 961657957  |a 988507410  |a 994585445  |a 1081191227  |a 1149252032  |a 1153478389  |a 1162056932  |a 1228588414  |a 1258399026 
020 |a 9240681523 
020 |a 9789240681521 
020 |a 9786610097432 
020 |a 6610097437 
020 |a 9789241209243 
020 |a 9241209240 
020 |a 9781280097430  |q (online) 
020 |a 1280097434 
020 |z 9241209240  |q (pbk.) 
035 |a (OCoLC)317384275  |z (OCoLC)70773992  |z (OCoLC)191039473  |z (OCoLC)496991904  |z (OCoLC)559332398  |z (OCoLC)646729274  |z (OCoLC)722341000  |z (OCoLC)728025062  |z (OCoLC)738625467  |z (OCoLC)827830783  |z (OCoLC)961657957  |z (OCoLC)988507410  |z (OCoLC)994585445  |z (OCoLC)1081191227  |z (OCoLC)1149252032  |z (OCoLC)1153478389  |z (OCoLC)1162056932  |z (OCoLC)1228588414  |z (OCoLC)1258399026 
037 |a 009743  |b MIL 
042 |a lccopycat 
050 4 |a RS189 
049 |a HCDD 
110 2 |a WHO Expert Committee on Biological Standardization.  |b Meeting  |n (52nd :  |d 2001 :  |c Geneva, Switzerland) 
245 1 0 |a WHO Expert Committee on Biological Standardization :  |b fifty-second report. 
260 |a Geneva :  |b World Health Organization,  |c 2004. 
300 |a 1 online resource (vii, 232 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
490 1 |a WHO technical report series ;  |v 924 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- General. Developments in biological standardization. Bioterrorism. International nonproprietary names for biotechnology-derived medicinal products -- International guidelines, recommendations, and other matters related to the manufacture and quality control of biologicals. Guidelines on clinical evaluation of vaccines: regulatory expectations. Group C meningococcal conjugate vaccines. Inactivated oral cholera vaccines. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. Pneumococcal conjugate vaccines. Potency assays for diphtheria and tetanus vaccines. Pertussis vaccines. Preventive human immunodeficiency virus vaccines. Cell substrate safety. Cell banks. Yellow fever. Poliomyelitis vaccine, oral. Transmissible spongiform encephalitis and the safety of biologicals. Antivenoms. Gene therapy. Discontinuation requirements -- International reference materials. Biological substances: international standards and reference reagents. International biological standards for in vitro diagnostic procedures. International reference materials for the diagnosis and study of transmissible spongiform encephalitis -- Antibodies. Human antibody against human platelet antigen 5b -- Blood products and related substances. International reference panels for the validation of serological and nucleic acid based test for the detection of hepatitis B, hepatitis C and human immunodeficiency virus in blood screening. Factors II, VII, X, plasma. Von Willebrand factor. Streptokinase. Unfractioned heparin and low-molecular-weight heparin -- Cytokines, growth factors and endocrinological substances. Human chorionic gonadotrophin. Ciliary neurotrophic factor. Prolactin and its glycosylated and non-glycosylated components -- Miscellaneous. Pertussis toxin standard -- Annex 1. Guidelines on clinical evaluation of vaccines: regulatory expectations -- Annex 2. Recommendations for the production and control of meningococcal group C conjugate vaccines -- Annex 3. Guidelines for the production and control of inactivated oral cholera vaccines -- Annex 4. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood products -- Annex 5. Biological substances: international standards and reference reagents -- Annex 6. Recommendations and guidelines for biological substances used in medicine and other documents. 
520 8 |a Annotation  |b This publication contains the recommendations of a WHO Expert Committee, which met in Geneva in November 2001, relating to quality and standardisation of biological products. Aspects discussed include: the production and quality control of meningococcal group C conjugate vaccines; guidelines for regulatory expectations for clinical evaluation of vaccines; guidelines for the production and quality control of inactivated oral cholera vaccines; guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products; information on the status and development of reference materials for various antibodies, antigens, blood products and related substances, cytokines, growth factors, and endocrinological substances. 
546 |a English. 
650 0 |a Biological products  |x Standards  |v Congresses. 
650 0 |a Drugs  |x Standards  |v Congresses. 
650 7 |a Biological products  |x Standards  |2 fast 
650 7 |a Drugs  |x Standards  |2 fast 
655 7 |a Conference papers and proceedings  |2 fast 
710 2 |a World Health Organization. 
758 |i has work:  |a WHO Expert Committee on Biological Standardization : Fifty-second Report (Text)  |1 https://id.oclc.org/worldcat/entity/E39PD36vGfHGyYF4mpdtDrXfdP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
773 0 |t Academic Search Complete.  |d EBSCO 
776 0 8 |i Print version:  |a WHO Expert Committee on Biological Standardization. Meeting (52th : 2001 : Geneva, Switzerland).  |t WHO Expert Committee on Biological Standardization.  |d Geneva : World Health Organization, 2004  |w (DLC) 2009659017 
830 0 |a Technical report series (World Health Organization) ;  |v 924. 
856 4 0 |u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=284745  |y Click for online access 
903 |a EBC-AC 
994 |a 92  |b HCD